Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England

被引：0
|
作者：
Vicki Osborne
Miranda Davies
Deborah Layton
Saad A. W. Shakir
机构：
[1] Drug Safety Research Unit,School of Pharmacy and Biomedical Science
[2] University of Portsmouth,Department of Epidemiology
[3] University of Florida,undefined
来源：
Drug Safety | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：267 / 275
页数：8
相关论文
共 50 条
  • [1] Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England
    Osborne, Vicki
    Davies, Miranda
    Layton, Deborah
    Shakir, Saad A. W.
    DRUG SAFETY, 2018, 41 (03) : 267 - 275
  • [2] Utilisation and Safety of Deferasirox (Exjade®): Results from an Observational Cohort Study in England
    Osborne, V.
    Davies, M.
    Layton, D.
    Shakir, S.
    DRUG SAFETY, 2015, 38 (10) : 1026 - 1027
  • [3] Utilisation and Safety of Deferasirox (Exjade®): Results from an Observational Cohort Study in England
    Osborne, Vicki
    Davies, Miranda
    Layton, Deborah
    Shakir, Saad A. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 77 - 77
  • [4] Utilisation and Safety of Deferasirox (Exjade®) in Older Adults: Results from an Observational Cohort Study in England
    Dhanda, S.
    Layton, D.
    Osborne, V.
    Shakir, S.
    DRUG SAFETY, 2017, 40 (10) : 978 - 978
  • [5] Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England
    Osborne, V.
    Davies, M.
    Layton, D.
    Shakir, S. A. W.
    EUROPEAN PSYCHIATRY, 2016, 33 : 61 - 67
  • [6] Utilisation of a once weekly injection for Type 2 Diabetes Mellitus: Interim results from an observational cohort study in England
    Osborne, V.
    Qayum, N.
    Coughtrie, A.
    Layton, D.
    Shakir, S.
    DRUG SAFETY, 2015, 38 (10) : 1026 - 1026
  • [7] Utilisation and Safety of Deferasirox (Exjade®) in Older Adults: Results form a Post Authorisation Safety Study (PASS)
    Dhanda, Sandeep
    Layton, Deborah
    Osborne, Vicki
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 312 - 313
  • [8] Utilisation and safety of asenapine in primary care in England: Results from a PASS
    Dhanda, Sandeep
    Coukan, Flavien
    Wise, Lesley
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 272 - 272
  • [9] Utilisation and Safety of Asenapine in Secondary Care in the UK: Results from the Observational Safety Evaluation of Asenapine (OBSERVA) Study
    Dhanda, S.
    Slade, J.
    Obsorne, V.
    Wise, L.
    Shakir, S.
    DRUG SAFETY, 2018, 41 (11) : 1129 - 1130
  • [10] Utilisation and safety of asenapine in secondary care in the United Kingdom: Results from the observational safety evaluation of asenapine (OBSERVA) study
    Dhanda, Sandeep
    Slade, Jan
    Osborne, Vicki
    Wise, Lesley
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 272 - 273
12345